Expression of Calcineurin Activity after Lung Transplantation: A 2-Year Follow-Up-Reference-Cited by-同舟云学术

Expression of Calcineurin Activity after Lung Transplantation: A 2-Year Follow-Up

Published:2013-03-25 Issue:3 Volume:8 Page:e59634
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Sanquer Sylvia,Amrein Catherine,Grenet Dominique,Guillemain Romain,Philippe Bruno,Boussaud Veronique,Herry Laurence,Lena Celine,Diouf Alphonsine,Paunet Michelle,Billaud Eliane M.,Loriaux Françoise,Jais Jean-Philippe,Barouki Robert,Stern Marc

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. International guidelines for the selection of lung transplant candidates;Am J Respir Crit Care Med,1998

2. Center-specific graft and patient survival rates: 1997 United Network for Organ Sharing (UNOS) report;HM Lin;JAMA,1998

3. Obliterative bronchiolitis after lung and heart-lung transplantation: an analysis of risk factors and management;K Bando;J Thorac Cardiovasc Surg,1995

4. Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation – early risk factors;LD Sharples;Transplantation,1996

5. Management of lung transplant rejection;EP Trulock;Chest,1993

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calcineurin inhibitors’ impact on cardiovascular and renal function, a descriptive study in lung transplant recipients from the North of Spain;Scientific Reports;2022-12-08

2. Getting immunosuppression just right: the role of clinical biomarkers in predicting patient response post solid organ transplantation;Expert Review of Clinical Pharmacology;2021-10-07

3. Sustained Inhibition of Calcineurin Activity With a Melt‐Dose Once‐daily Tacrolimus Formulation in Renal Transplant Recipients;Clinical Pharmacology & Therapeutics;2021-03-25

4. Maintenance Immunosuppression in Solid Organ Transplantation: Integrating Novel Pharmacodynamic Biomarkers to Inform Calcineurin Inhibitor Dose Selection;Clinical Pharmacokinetics;2020-07-27

5. Pharmacogenetic—Whole blood and intracellular pharmacokinetic—Pharmacodynamic (PG-PK2-PD) relationship of tacrolimus in liver transplant recipients;PLOS ONE;2020-03-12